Miele et al. showed that the presence of the KLF6 IVS1-27G>A SNP, which was demonstrated to reduce fibrogenesis in HSCs, was associated with less fibrosis in a UK cohort with biopsy-proven NAFLD patients. The gene discussed is KLF6; the disease is metabolic dysfunction-associated steatotic liver disease.